Report Company Directory

ONCOCLINICAS BRASIL SERVICOS MEDICOS SA

• Itaú BBA on Healthcare: Pulse Check #43 - HAPV Reports -28k for the Month; SULA Continues to Advance with +78k MoM by Itau
• Itaú BBA on Healthcare & Education: 18th Itaú BBA LatAm CEO Conference – Healthcare & Education Feedback by Itau
• Itaú BBA on Oncoclínicas: Lower Growth Leads to EBITDA YoY Pressure by Itau
• Itaú BBA on Healthcare: Our Take on Pool Price Hikes for 2025 Cycle by Itau
• Itaú BBA on Healthcare: Proposed Regulatory Changes Update: Detailed Review of Technical Notes by Itau
• Itaú BBA on Healthcare: 1Q25 Earnings Preview by Itau
• Itaú BBA on Healthcare: Pulse Check #41 - HAPV Loses 90k YTD; OK Print for SULA by Itau
• Itaú BBA on Oncoclínicas: Focus on Working Capital and FCF Leads to Topline Deceleration; Net Debt Reduction as the Highlight by Itau
• Itaú BBA on Healthcare: Highlights From Healthcare Day 2025 – When the Going Gets Tough, the Tough Get Going by Itau
• Itaú BBA on Brazil Equity Strategy: Corporate Insider Trading Disclosure by Itau

ONCOCROSS CO. LTD.

Oncocyte

• Oncocyte Changes Name to Insight Molecular Diagnostics Inc. (iMDx), Moves Headquarters to Nashville by GlobeNewsWire
• Medicare Boosts Reimbursement for Oncocyte’s Flagship Technology by GlobeNewsWire
• Oncocyte Reports Q1 2025 Results and Business Progress by GlobeNewsWire
• Oncocyte to Release First Quarter 2025 Results on May 12, 2025 by GlobeNewsWire
• Oncocyte Provides Positive Update on Clinical Trial Progress by GlobeNewsWire
• Oncocyte’s Proprietary Assay Demonstrates Long-Term Clinical Validity by GlobeNewsWire
• Oncocyte to Participate in 24th Annual Needham Virtual Healthcare Conference by GlobeNewsWire
• Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts by GlobeNewsWire
• Oncocyte to Release Fourth Quarter 2024 Results on March 24, 2025 by GlobeNewsWire
• Oncocyte to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference by GlobeNewsWire

ONCOCYTE CORPORATION

• Monthly Insider Special Screens: March 1, 2025 by InsiderInsights.com
• InsiderInsights Weekly Report: February 22, 2025 by InsiderInsights.com
• InsiderInsights Weekly Report: February 15, 2025 by InsiderInsights.com
• InsiderInsights.com Daily Ratings Report: February 11, 2025 by InsiderInsights.com
• InsiderInsights.com Daily Ratings Report: February 10, 2025 by InsiderInsights.com
• InsiderInsights Weekly Report: January 25, 2025 by InsiderInsights.com
• InsiderInsights Weekly Report: January 18, 2025 by InsiderInsights.com
• InsiderInsights.com Daily Ratings Report: January 15, 2025 by InsiderInsights.com
• InsiderInsights Weekly Report: January 11, 2025 by InsiderInsights.com
• InsiderInsights Weekly Report: January 4, 2025 by InsiderInsights.com

Oncodesign SA

• CIC Market Solutions Morning News Analyser - CIC Market Solutions Morning Analyser - 05/12/2024 by CIC Market Solutions
• Value Observer - Forum CIC Market Solutions 2024 : Comptes rendus des réunions by CIC Market Solutions
• CIC Market Solutions Morning News Analyser - CIC Market Solutions Morning Analyser - 30/08/2024 by CIC Market Solutions
• CIC Market Solutions Morning News Analyser - CIC Market Solutions Morning Analyzer - 24/01/2023 by CIC Market Solutions
• ONCODESIGN: COMMUNIQUE DU 13 DECEMBRE 2022 RELATIF À LA MISE EN OEUVRE DU RETRAIT OBLIGATOIRE VISANT LES ACTIONS DE LA SOCIÉTÉ ONCODESIGN... by BusinessWire
• ONCODESIGN: OFFRE PUBLIQUE D’ACHAT SIMPLIFIÉE VISANT LES ACTIONS DE LA SOCIÉTÉ by BusinessWire
• AUTRES INFORMATIONS RELATIVES AUX CARACTÉRISTIQUES, NOTAMMENT JURIDIQUES, FINANCIÈRES ET COMPTABLE DE LA SOCIETE ONCODESIGN ... by BusinessWire
• OFFRE PUBLIQUE D’ACHAT SIMPLIFIEE VISANT LES ACTIONS DE LA SOCIÉTÉ ONCODESIGN by BusinessWire
• ONCODESIGN : RELATIF A LA MISE A DISPOSITION DE LA NOTE D’INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE CANCER BUSTER BIDCO SAS ... by BusinessWire
• NOTE EN REPONSE RELATIVE A L’OFFRE PUBLIQUE D’ACHAT SIMPLIFIEE VISANT LES ACTIONS DE LA SOCIETE ONCODESIGN by BusinessWire